IpamorelinAlso known as: NNC 26-0161, Ipamorelin acetate Mechanism of Action Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue receptor (GHS-R1a) agonist
Some patients report that the oral version, because it is taken daily in smaller doses, may lead to smoother levels of the medication in the body, potentially reducing the intensity of the peaks that can sometimes cause nausea shortly after a weekly injection
This is a normal part of your body adjusting, and they typically settle quickly as your system adapts
This means they mimic the action of a natural hormone called GLP-1 which helps regulate blood sugar by stimulating insulin release and reducing glucose production in the liver
Weeks 1-4: 0.25 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 5-8: 0.5 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 9-12: 1.0 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 13-16: 1.7 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Week 17 and beyond: 2.4 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Some providers modify this schedule based on individual tolerance
doi: 10.3390/ijms23010280 184 MatthayM